Synthesis, Antibacterial Activities, Mode of Action and Acute Toxicity Studies of New Oxazolidinone-Fluoroquinolone Hybrids

Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview

(2019) Roberto Vivas et al.   Microbial Drug Resistance

Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors

(2019) Ehab S. Taher et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Rapid emergence of highly variable and transferable oxazolidinone and phenicol resistance gene optrA in German Enterococcus spp. clinical isolates

(2018) Jennifer K. Bender et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Burden of antimicrobial resistance in an era of decreasing susceptibility

(2017) Glenn S. Tillotson et al.   Expert Review of Anti-Infective Therapy

Mechanisms of quinolone action and resistance: where do we stand?

(2017) Susana Correia et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections

(2017) Bingyun Li et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Hybrid antibiotics – clinical progress and novel designs

(2016) Alastair L. Parkes et al.   Expert Opinion on Drug Discovery

Overview: Global and Local Impact of Antibiotic Resistance

(2016) Richard R. Watkins et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Revised Estimates for the Number of Human and Bacteria Cells in the Body

(2016) Ron Sender et al.   PLOS BIOLOGY

Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection

(2015) Thomas Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Susceptibility ofClostridium difficileisolates from a Phase 2 clinical trial of cadazolid and vancomycin inC. difficileinfection

(2015) D. N. Gerding et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Structural insights into species-specific features of the ribosome from the pathogenStaphylococcus aureus

(2015) Zohar Eyal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The spectroscopic and quantum chemical studies of 3,4-difluoroaniline

(2015) Etem Kose et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials

(2014) Abrar K Thabit et al.   EXPERT OPINION ON PHARMACOTHERAPY

Résistance aux fluoroquinolones en 2013 : quel impact pour l’interniste ?

(2014) V. de Lastours et al.   REVUE DE MEDECINE INTERNE

Investigations of the Mode of Action and Resistance Development of Cadazolid, a New Antibiotic for Treatment of Clostridium difficile Infections

(2013) Hans H. Locher et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses

(2013) D. Baldoni et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The oxazolidinones: past, present, and future

(2011) Karen Joy Shaw et al.   Annals of the New York Academy of Sciences

Antistaphylococcal Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic

(2011) Johanne Blais et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance

(2010) Varvara Pokrovskaya et al.   Expert Opinion on Drug Discovery

Design, Synthesis, and Evaluation of Novel Fluoroquinolone−Aminoglycoside Hybrid Antibiotics

(2009) Varvara Pokrovskaya et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors

(2009) Nicolas Matuszak et al.   JOURNAL OF MEDICINAL CHEMISTRY

In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus

(2008) G. T. Robertson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY